HCV Disease Progression
Coverage of the 2012 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 13 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2012) in Boston, November 9-13, 2012.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
HIVandHepatitis.com AASLD 2012 conference section
11/13/12
Hepatitis C Raises Risk of Both Liver-Related and Non-Liver Deaths
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 24 July 2012 00:00
- Written by Liz Highleyman
Overall mortality from both liver-related disease and non-liver conditions -- including some cancers -- is significantly increased in people with chronic hepatitis C virus (HCV) infection compared with uninfected individuals, according to a study published in the July 17, 2012, advance online edition of the Journal of Infectious Diseases.
Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients
- Details
- Category: Fibrosis & Cirrhosis
- Published on Friday, 13 July 2012 00:00
- Written by Liz Highleyman
Insulin resistance is common among HIV positive people with hepatitis C virus (HCV) coinfection and is strongly associated with progression to liver fibrosis over time, Canadian researchers reported in the June 27, 2012, advance online edition of AIDS.
FibroScan Liver Stiffness Measurement Predicts Liver Failure and Death
- Details
- Category: Fibrosis & Cirrhosis
- Published on Friday, 13 July 2012 00:00
- Written by Liz Highleyman
Transient elastography, better known as FibroScan, is an accurate method for predicting liver-related clinical events and death in HIV positive people coinfected with hepatitis C virus (HCV), according to a study described in the July 2012 issue of Hepatology.
Hepatitis C Treatment Reduces HIV Progression and Death in HIV/HCV Coinfected
- Details
- Category: HCV Treatment
- Published on Tuesday, 05 June 2012 00:00
- Written by Liz Highleyman
HIV positive people who achieve sustained virological response (SVR) to interferon-based therapy for chronic hepatitis C not only lower their risk of liver-related complications and death, but also have lower rates of HIV disease progression and all-cause mortality, according to a study published in the May 18, 2012, advance online edition of Clinical Infectious Diseases.
More Articles...
- Coffee May Reduce Fibrosis in People with Fatty Liver Disease
- Combining HCV Med Boceprevir with Boosted HIV Protease Inhibitors Can Lower Drug Levels
- European Study Does Not See Rapid Long-Term Liver Fibrosis in HIV/HCV Coinfected People
- Brivanib Does Not Improve Liver Cancer Survival for Treatment-Experienced Patients
Web Design and Development by